Site Map Menu Items Home Corporate Governance Constitution Code of Conduct and Ethics Board Charter Audit Committee Charter Remuneration Committee Charter Nominations Committee Charter Investor Information Publications Annual and Half Year Reports Presentations and Shareholder Notices Archive Contacts News ArborGen to Acquire World-Class Commercial Tree Improvement Operations Rubicon Group Annual Review - 2007 ArborGen Transactions Close Rubicon Interim Review For the Period Ended 31 December 2007 Rubicon Annual Review for the year ended 30 June 2008 Rubicon Interim Review for the six months to 31 December 2008 Rubicon confirms receipt of Notice of Intention to make a Partial Takeover Offer of Rubicon Rubicon Releases Independent Adviser's Report on Knott Takeover Offer Rubicon announces results of Knott Takeover Offer Rubicon announces adjustment to Knott Takeover Offer voting statistics Rubicon Announces Date of 2009 Annual Shareholders' Meeting Rubicon Annual Review - For the Year Ended 30 June 2009 2009 Annual Shareholders Meeting Voting Results Rubicon Capital Raising Announced Rubicon Capital Raising Completed Fully Subscribed Rubicon Announces Date of 2010 Annual Shareholders' Meeting Rubicon Annual Review - For the Year Ended 30 June 2010 Rubicon announces the sale of Challenge to Caltex NZ, and an intention to return further capital to shareholders Rubicon announces details of share buy-back and small shareholdings programme Rubicon announces the result of their arbitration with Genesis Rubicon announces new Directors Rubicon Announces strong six months results Rubicon announces extension of NZSE waiver Rubicon not to seek full ASX listing Rubicon in discussions with Fletcher Challenge Forests Rubicon announces strong maiden profit result Rubicon acquires Tahorakuri forest Rubicon to appoint new directors Rubicon confirms changes in Board composition Rubicon voting rights to be confirmed US$64 million Tahorakuri Forest Estate purchase price confirmed Rubicon's Special Shareholders' Meeting date set Rubicon voting rights confirmed Rubicon to look to alternatives Rubicon approves GPG "variation" Rubicon responds to GPG's partial Offer Rubicon responds to GPG letters ArborGen Transfer Issue Raised Under GPG Partial Takeover Offer for Rubicon Rubicon confirms lapse of GPG partial takeover offer Rubicon responds to NZSE waiver decision Rubicon supports proposed return of capital by FCF Rubicon increases shareholding in FCF to 19.997% Rubicon comments on FCF Preference Shares High Court rules on GPG / Perry litigation Rubicon Announces $14.1 Million Profit for 2003 Financial Year Rubicon announces date of ASM 2002 Annual Shareholders Meeting Voting Results 2003 Annual Shareholders Meeting Voting Results Court of Appeal rules on GPG v Perry litigation Interim Report - September 2003 Biotechnology Venture Eyes New Horizons Rubicon issues Takeover Notice to Tenon - $1.85 per share Rubicon Forests to despatch Offer document to Tenon shareholders Rubicon Announces Results for 2003/4 Financial Year Rubicon Restructures Board Rubicon Option Exercise Rubicon Announces Date of 2004 Annual Shareholders' Meeting 2004 Annual Shareholders Meeting Voting Results Rubicon Review - Six Months to 30 September 2004 Rubicon to Change Balance Date Rubicon Announces Date of 2005 Annual Shareholders' Meeting Rubicon adopts United States dollars as its functional currency Rubicon 2005 Review Rubicon Annual Shareholders' Meeting - speeches 2005 Annual Shareholders Meeting Voting Results Rubicon buyback documentation to be despatched this week Rubicon Announces Further Buyback Plan Early Adopter of International Financial Reporting Standards Rubicon Interim Report - six months to 31 December 2005 Rubicon Announces Date of 2006 Annual Shareholders' Meeting Rubicon 2006 Review Rubicon Announces Sale of Argentine Operations 2006 Annual Shareholders Meeting Voting Results Rubicon Interim Report - for the period ended 31 December 2006 Rubicon Implements Employee Equity Plan ArborGen to be partner in US$125 million bioenergy research centre ArborGen receives USDA approval for full-rotation cold-tolerant field trial ArborGen to Participate in International Eucalyptus Genome Project